DNA CIK: 1830214

Ginkgo Bioworks Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
1.72
FY22:
1.45
FY23:
1.00
FY24:
0.60
FY25:
0.47
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.35
FY22:
1.09
FY23:
0.66
FY24:
0.77
FY25:
0.65
Total assets
Change from FY21 to FY25
billions USD
FY21:
2.07
FY22:
2.54
FY23:
1.67
FY24:
1.38
FY25:
1.12

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.13
FY22:
0.17
FY23:
0.16
FY24:
0.11
FY25:
0.10
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.37
FY22:
0.63
FY23:
0.40
FY24:
0.55
FY25:
0.52
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.51
FY22:
1.74
FY23:
1.10
FY24:
0.72
FY25:
0.51
Total liabilities & equity
Change from FY22 to FY25
billions USD
FY21:
–
FY22:
2.54
FY23:
1.67
FY24:
1.38
FY25:
1.12

All amounts in billions USD Data source:SEC EDGAR